Wen Qi is an Associate at Lightstone Singapore Pte. Ltd., where she evaluates new investment opportunities in the biopharmaceutical and medical device sectors out of the firm’s Singapore office.
Wen Qi attained her B.Sc. in Molecular and Cellular Biology at Johns Hopkins University, and her PhD in Immunology at Stanford University under the guidance of Professor Gerald Crabtree, a Howard Hughes Medical Institutes investigator. She was also the recipient of the National Science Scholarship from the Agency for Science, Technology and Research (A*STAR) Singapore. While at Stanford, she enrolled in the Program in Innovation and Entrepreneurship at the Stanford School of Business where she learned business fundamentals and had hands-on experience at developing an idea to business plan. Since moving to Singapore, Wen Qi has been actively involved in the Executive Committee of Biotech Connection Singapore, which aims to promote the life science entrepreneurship eco-system in Singapore by providing a platform for innovators, academics, and investors to come together.
Ph.D. in Immunology from Stanford University
B.Sc. in Molecular and Cellular Biology from Johns Hopkins University